DK0494317T4 - SIV cpz-ant-retrovirus og anvendelse deraf - Google Patents

SIV cpz-ant-retrovirus og anvendelse deraf

Info

Publication number
DK0494317T4
DK0494317T4 DK90111364T DK90111364T DK0494317T4 DK 0494317 T4 DK0494317 T4 DK 0494317T4 DK 90111364 T DK90111364 T DK 90111364T DK 90111364 T DK90111364 T DK 90111364T DK 0494317 T4 DK0494317 T4 DK 0494317T4
Authority
DK
Denmark
Prior art keywords
virus
protein
ant
retrovirus
htlv
Prior art date
Application number
DK90111364T
Other languages
English (en)
Other versions
DK0494317T3 (da
Inventor
Peter Prof Dr Piot
Der Groen Guido Dr Sc Van
Eric Dr Delaporte
Martine Dr Peeters
Original Assignee
Innogenetics Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8204103&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0494317(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Innogenetics Nv filed Critical Innogenetics Nv
Application granted granted Critical
Publication of DK0494317T3 publication Critical patent/DK0494317T3/da
Publication of DK0494317T4 publication Critical patent/DK0494317T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1143—Gag-pol proteins, e.g. p17or p24
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK90111364T 1990-06-15 1990-06-15 SIV cpz-ant-retrovirus og anvendelse deraf DK0494317T4 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90111364A EP0494317B2 (en) 1990-06-15 1990-06-15 The retrovirus SIV cpz-ant and its uses

Publications (2)

Publication Number Publication Date
DK0494317T3 DK0494317T3 (da) 1994-10-10
DK0494317T4 true DK0494317T4 (da) 2001-04-02

Family

ID=8204103

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90111364T DK0494317T4 (da) 1990-06-15 1990-06-15 SIV cpz-ant-retrovirus og anvendelse deraf

Country Status (10)

Country Link
US (1) US5624795A (da)
EP (1) EP0494317B2 (da)
JP (1) JPH06500230A (da)
AT (1) ATE105857T1 (da)
AU (1) AU657479B2 (da)
CA (1) CA2085370A1 (da)
DE (1) DE69009066T3 (da)
DK (1) DK0494317T4 (da)
ES (1) ES2053014T5 (da)
WO (1) WO1991019785A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5470572A (en) * 1993-07-16 1995-11-28 University Of Puerto Rico Non-infectious simian immunodeficiency virus particles produced by cell line CRL 11393
US20030215793A1 (en) * 2002-01-17 2003-11-20 Hahn Beatrice H. Complete genome sequence of a simian immunodeficiency virus from a wild chimpanzee
US9644187B2 (en) 2010-04-14 2017-05-09 Emd Millipore Corporation Methods of producing high titer, high purity virus stocks and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR930000189B1 (ko) † 1984-10-18 1993-01-11 앵스뛰띠 빠스뙤르 임파선증과 후천성 면역 결핍증 바이러스의 항원을 제조하는 방법 및 이 항원에 대한 항체의 생산 방법
AU601397B2 (en) † 1986-01-22 1990-09-13 Institut Pasteur Retrovirus of the hiv-2 type susceptible of inducing aids, and its antigenic and nucleic constituents
WO1989009815A1 (en) * 1988-04-04 1989-10-19 Research Corporation Technologies, Inc. Novel virus of the hiv-2 family and methods of detection therefor
EP0657532B1 (en) * 1988-06-09 2003-12-17 N.V. Innogenetics S.A. HIV-3 retrovirus strains and their use
FR2644176B1 (fr) † 1989-03-07 1993-10-08 Franceville Ctre Internal Recher Retrovirus viscpz infectant naturellement le chimpanze, fragments d'adn de ce retrovirus, procede de preparation d'une proteine et/ou d'une enzyme de ce virus et leurs utilisations

Also Published As

Publication number Publication date
AU7967091A (en) 1992-01-07
EP0494317A1 (en) 1992-07-15
AU657479B2 (en) 1995-03-16
US5624795A (en) 1997-04-29
EP0494317B2 (en) 2000-12-27
DE69009066D1 (de) 1994-06-23
JPH06500230A (ja) 1994-01-13
ES2053014T5 (es) 2001-02-16
ATE105857T1 (de) 1994-06-15
DE69009066T3 (de) 2001-07-19
CA2085370A1 (en) 1991-12-16
WO1991019785A1 (en) 1991-12-26
DK0494317T3 (da) 1994-10-10
DE69009066T2 (de) 1994-10-06
EP0494317B1 (en) 1994-05-18
ES2053014T3 (es) 1994-07-16

Similar Documents

Publication Publication Date Title
Kornfeld et al. Cloning of HTLV-4 and its relation to simian and human immunodeficiency viruses
Yu et al. The vpx gene of simian immunodeficiency virus facilitates efficient viral replication in fresh lymphocytes and macrophage
LaBranche et al. A single amino acid change in the cytoplasmic domain of the simian immunodeficiency virus transmembrane molecule increases envelope glycoprotein expression on infected cells
Terwilliger et al. Effects of mutations within the 3'orf open reading frame region of human T-cell lymphotropic virus type III (HTLV-III/LAV) on replication and cytopathogenicity
JP3140757B2 (ja) パッケージング欠陥ｈｉｖプロウイルス、細胞系及びその使用
Weiss Retrovirus classification and cell interactions
FI903866A0 (fi) Terapeutiskt aktiva albuminderivat.
DE69632256D1 (de) Antivirale proteine, dafür kodierende dna, und deren verwendung
EP2267452B8 (en) A soluble complex comprising a retroviral surface glycoprotein
AU1225088A (en) Peptides having immunological properties 2-hiv-2
DK33190D0 (da) Hiv-3 retrovirus og anvendelse heraf
DE3855134D1 (de) Monoklonale menschliche antikörper gegen hiv-i
Hirsch et al. Molecular cloning of SIV from sooty mangabey monkeys
Sanchez-Palomino et al. Dilute passage promotes expression of genetic and phenotypic variants of human immunodeficiency virus type 1 in cell culture
Yu et al. Vpx of simian immunodeficiency virus is localized primarily outside the virus core in mature virions
DK0494317T4 (da) SIV cpz-ant-retrovirus og anvendelse deraf
Dirckx et al. Mutation of conserved N-glycosylation sites around the CD4-binding site of human immunodeficiency virus type 1 GP120 affects viral infectivity
Kodama et al. Molecular changes associated with replication of simian immunodeficiency virus in human cells
Shinji et al. Clonal analysis of functional differences among strains of human immunodeficiency virus (HIV)
Collette et al. The primate lentivirus-encoded Nef protein can regulate several steps of the viral replication cycle
Hunsmann Subunit vaccines against exogenous retroviruses: overview and perspectives
FR2647809B1 (fr) Amorces oligonucleotidiques pour l'amplification du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications au diagnostic in vitro des infections dues a ces virus
Resnick et al. Human T-cell lymphotropic viruses: Syncytia formation
Le Guenno et al. HIV2 is responsible for AIDS cases in Senegal
DE68925191D1 (de) Peptide mit schutzeigenschaften gegen ein pathogenes virus des hiv-typs in sensitiven zellen